E13. Identification of genomic changes associated with resistanceto standard chemotherapy in a xenograft model of human NSCLC
Timon P.H. Buys(University of British Columbia), Wan L. Lam(University of British Columbia), John C. English(University of British Columbia Hospital), Nevin Murray(BC Cancer Agency), Cathie Garnis(Occupational Cancer Research Centre), Victor Ling(BC Cancer Agency), Stephen S.Y. Lam, Yuzhuo Wang(BC Cancer Agency), Julia Flint(BC Cancer Agency), Jun Guan(Qingdao University), John Yee(BC Cancer Agency), Calum MacAulay(BC Cancer Agency)
Cited by 1
Related Papers
Probability of Cancer in Pulmonary Nodules Detected on First Screening CT
|New England Journal of Medicine|2013|1.4k
Androgen Suppression Combined with Elective Nodal and Dose Escalated Radiation Therapy (the ASCENDE-RT Trial): An Analysis of Survival Endpoints for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost to a Dose-Escalated External Beam Boost for High- and Intermediate-risk Prostate Cancer
|International Journal of Radiation Oncology*Biology*Physics|2016|736
Identifying Individuals with Physcian Diagnosed COPD in Health Administrative Databases
|COPD Journal of Chronic Obstructive Pulmonary Disease|2009|664
Dynamics of genomic clones in breast cancer patient xenografts at single-cell resolution
|Nature|2014|642
Identifying Patients with Physician‐Diagnosed Asthma in Health Administrative Databases
|Canadian Respiratory Journal|2009|439